Israel vs Latvia: Coverage of the human papillomavirus vaccine
Israel
51
in 2025
Latvia
54
in 2025
Israel rank
62nd
Latvia rank
60th
Coverage of the human papillomavirus vaccine over time
- Israel
- Latvia
How they compare
Latvia currently reports 54 against 51 in Israel, a difference of 3.
That makes Latvia's figure about 1.1 times Israel's.
The two have swapped places 2 times across 10 shared years of data; in 2016 it was Latvia ahead.
Israel ranks 62nd and Latvia ranks 60th of 85 countries.
Israel has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Israel | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 52.5 | 41.5 | 11 | Israel |
| 2020s | 54 | 44.33 | 9.67 | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher coverage of the human papillomavirus vaccine, Israel or Latvia?
- Latvia, at 54 against 51 in Israel as of 2025.
- What is the difference in coverage of the human papillomavirus vaccine between Israel and Latvia?
- 3, with Latvia ahead.
- How many years of comparable data are there for Israel and Latvia?
- 10 years are reported by both, from 2016 to 2025.
- How do Israel and Latvia rank globally for coverage of the human papillomavirus vaccine?
- Israel ranks 62nd and Latvia ranks 60th of 85 countries.
- Where does this data come from?
- Our World in Data, published as Coverage of the human papillomavirus vaccine. Statizoid refreshes it automatically from the source and publishes the full history for both places.